Beyond a Single Drug: Why Oncotelic’s (OTLC) Integrated Platform Is Starting to Draw Attention
Years of research infrastructure are beginning to converge into a platform strategy with significant implications Most small-cap biotechnology companies tell investors a familiar story:…
Read More »